Cargando…

Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis

OBJECTIVES: In this study, we aimed to study the rate of autoantibodies against type I interferons (IFNs) in patients with COVID-19 and analyze its dependence on severity of infection and some other variables. METHODS: A systemic review with the search terms: “COVID-19” or “SARS-CoV-2” and “autoanti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xi, Tang, Qi, Li, Hongmei, Jiang, Honglin, Xu, Jing, Bergquist, Robert, Qin, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005838/ https://www.ncbi.nlm.nih.gov/pubmed/36907547 http://dx.doi.org/10.1016/j.ijid.2023.03.011

Ejemplares similares

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
por: Koning, Rutger, et al.
Publicado: (2021)

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
por: de Prost, Nicolas, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
por: van der Wijst, Monique G. P., et al.
Publicado: (2021)

Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
por: Akbari, Abolfazl, et al.
Publicado: (2023)

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
por: Busnadiego, Idoia, et al.
Publicado: (2022)

COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman
por: Ning, Wangbin, et al.
Publicado: (2022)

Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
por: Burbelo, Peter D., et al.
Publicado: (2019)

Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2021)

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons
por: Saheb Sharif-Askari, Fatemeh, et al.
Publicado: (2023)

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
por: Bastard, Paul, et al.
Publicado: (2021)

Autoantibodies to Interferons in Infectious Diseases
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2023)

Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production
por: Castañeda-Delgado, Julio E., et al.
Publicado: (2017)

Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Meager, Anthony, et al.
Publicado: (2006)

Autoantibodies against type I IFNs in patients with critical influenza pneumonia
por: Zhang, Qian, et al.
Publicado: (2022)

The Cytokine Profile in Different Stages of Schistosomiasis Japonica
por: Wang, Xi, et al.
Publicado: (2023)

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles
por: Reynolds, John A., et al.
Publicado: (2019)

Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
por: Bastard, Paul, et al.
Publicado: (2020)

450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient
por: Yee, Debra, et al.
Publicado: (2021)

Type I interferon
por: Niewold, Timothy B.
Publicado: (2020)

Extrapancreatic Autoantibody Profiles in Type I Diabetes
por: Burbelo, Peter D., et al.
Publicado: (2012)

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets
por: Bradford, Hannah F., et al.
Publicado: (2023)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial
por: Alotaibi, Faizah, et al.
Publicado: (2023)

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
por: de Laat, Bas, et al.
Publicado: (2010)

Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019
por: Shaw, Elana R, et al.
Publicado: (2021)

Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked
por: Rosenberg, Jacob M., et al.
Publicado: (2018)

Porcine type I interferons: polymorphic sequences and activity against PRRSV
por: Sang, Yongming, et al.
Publicado: (2011)

Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies
por: Chruewkamlow, Nuttapol, et al.
Publicado: (2016)

Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
por: da Silva, Rafaela Pires, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
por: Le Voyer, Tom, et al.
Publicado: (2023)

Type-I interferons in atherosclerosis
por: Chen, Hung-Jen, et al.
Publicado: (2019)

Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
por: Ghale, Rajani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jmk9bi875m1mgoqademsmcljn